XML 61 R46.htm IDEA: XBRL DOCUMENT
v3.24.0.1

STOCKHOLDERS' EQUITY (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2023
Stockholders' Equity Note [Abstract] |
Schedule of Accumulated Other Comprehensive Income (Loss) | Changes in AOCI by component, net of tax, for the years ended December 31, 2023, 2022, and 2021 are summarized as follows (in thousands):
|  | Foreign Currency Translation |  | Derivative Instruments |  | Total
Balances at December 31, 2020 |  | $ | (2,182) |  |  | $ | 9,815 |  |  | $ | 7,633 |
Net unrealized gains (losses) arising during the period(a) |  | 193 |  |  | 34,127 |  |  | 34,320 |
Less: Net realized gains (losses) reclassified to net loss(b) |  | — |  |  | 41,094 |  |  | 41,094 |
Net change during the period |  | 193 |  |  | (6,967) |  |  | (6,774) |
Balances at December 31, 2021 |  | (1,989) |  |  | 2,848 |  |  | 859 |
Net unrealized gains (losses) arising during the period(c) |  | 198 |  |  | 1,727 |  |  | 1,925 |
Less: Net realized gains (losses) reclassified to net income(d) |  | — |  |  | 3,666 |  |  | 3,666 |
Net change during the period |  | 198 |  |  | (1,939) |  |  | (1,741) |
Balances at December 31, 2022 |  | (1,791) |  |  | 909 |  |  | (882) |
Net unrealized gains (losses) arising during the period(e) |  | 975 |  |  | (3,063) |  |  | (2,088) |
Less: Net realized gains (losses) reclassified to net income(f) |  | — |  |  | (2,542) |  |  | (2,542) |
Net change during the period |  | 975 |  |  | (521) |  |  | 454 |
Balances at December 31, 2023 |  | $ | (816) |  |  | $ | 388 |  |  | $ | (428) |
————————— (a) Derivative instruments net of $11.5 million of tax expense for the year ended December 31, 2021. (b) Derivative instruments net of $13.8 million of tax expense for the year ended December 31, 2021. (c) Derivative instruments net of $0.6 million of tax expense for the year ended December 31, 2022. (d) Derivative instruments net of $1.2 million of tax expense for the year ended December 31, 2022. (e) Derivative instruments net of $1.0 million of tax benefit for the year ended December 31, 2023. (f) Derivative instruments net of $0.8 million of tax benefit for the year ended December 31, 2023.

X
- Definition Tabular disclosure of the components of accumulated other comprehensive income (loss). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 14A -Publisher FASB -URI https://asc.fasb.org//1943274/2147482790/220-10-45-14A Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 + Details
Name: | us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration